CHRE concerned about representation on regulatory review
Concern over the absence of representatives of many regulatory bodies from a Department of Health review group has been expressed within the Council for Healthcare Regulatory Excellence. But the council left it to individual regulators to take up the matter with the DoH.
Only two of the six health regulators responsible for 19 professions
under review — the Nursing and Midwifery Council and the Health
Professions Council — are represented on the group. Instead, most,
including the Royal Pharmaceutical Society, are restricted to participation
in a reference group conference, which will meet for the first time in
July. No details of any other reference group activities are available.
The review (PDF 20K), chaired by the DoH’s workforce director Andrew
Foster (PJ, 19 March, p323 and
26 March, p349),
was discussed at a closed session of the CHRE’s April meeting.
The CHRE chairwoman, Jane Wesson, and director, Sandy Forrest, are members
of the review group, as is the chief pharmaceutical officer for England,
Jim Smith. It met for the first time on 1 April and will meet monthly
until it reports in December.
The review group is concerned with CPD systems and the appraisal of non-medical
health professionals and possible progress towards systems of revalidation.
It is also to consider the role, structure, functions and number of non-medical
health regulators. |
The
Pharmaceutical Journal
Acrobat
Reader